Advanced ovarian cancers are highly metastatic due to frequent peritoneal dissemination,
resulting in dismal prognosis. Here we report the functions of cancer-derived extracellular …

Exosome cargoes are highly varied and include proteins, small RNAs, and genomic DNA (gDNA).
The presence of gDNA suggests that different intracellular compartments contribute to …

Target-protein degradation is an emerging field in drug discovery and development. In
particular, the substrate-receptor proteins of the cullin–ubiquitin ligase system play a key role in …

Cancer-associated fibroblasts (CAFs), one of the major components of a tumour microenvironment,
comprise heterogeneous populations involved in tumour progression. However, it …

A major obstacle to improving prognoses in ovarian cancer is the lack of effective screening
methods for early detection. Circulating microRNAs (miRNAs) have been recognized as …

Pladienolide is a naturally occurring macrolide that binds to the SF3b complex to inhibit
mRNA splicing. It has not been fully validated whether the splicing impairment is a relevant …

Extracellular vesicles (EVs) such as exosomes are released by all living cells and contain
diverse bioactive molecules, including nucleic acids, proteins, lipids, and metabolites. …

Mutations within the catalytic domain of the histone methyltransferase EZH2 have been
identified in subsets of patients with non-Hodgkin lymphoma (NHL). These genetic alterations …

Ovarian cancer is the leading cause of gynecologic cancer mortality, due to the difficulty of
early detection. Current screening methods lack sufficient accuracy, and it is still challenging …

We have developed a systematic strategy for drug target identification. This consists of the
following sequential steps: (1) enrichment of total binding proteins using two differential affinity …